Champions Oncology (CSBR) stock forecast for 2022 – 2027

Are you interested in Champions Oncology, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CSBR stock price in 2022-2027. Is CSBR a good long term stock? When should I take profit in Champions Oncology stock? Buy or sell stock? Will CSBR stock price go up? What are analysts’ forecasts for CSBR stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CSBR stock returns are also predicted based on historical data.

According to our research, CSBR stock is a acceptable long-term investment. CSBR share price has been in a bull cycle for the past year. Champions Oncology, Inc. stock trend is positive.

Champions Oncology company info

Industry Biotechnology
Address One University Plaza, Hackensack, NJ, 07601, United States
Website https://www.championsoncology.com

Forecasting

52 Week High: 8.55344 USD
52 Week Low: 6.968 USD
1 Year Forecast: 8.81528 USD
5 Year Forecast: 12.4311 USD

Agilent Technologies info

Market Cap: 108.39M
52 Week Change: -3.158%
52 Week High: 14.68 USD
52 Week Low: 7.6 USD
Beta: 0.658372
50 Day Moving Average: 8.01
90 Day Moving Average: 8.507
200 Day Moving Average: 9.47
Resistance Level: 8.00613
Pivot Point: 7.84294
Support Level: 7.77826
Enterprise Value: 113,131,024
Forward P/E: 33.91
Forward EPS: 0.23
Profit Margin: 0.88%
Shares Outstanding: 13,514,900
EBITDA: 67.10
Held Percent Institutions: 64.96%
PEG Ratio (5Y): 8.93
Trailing EPS: 0.02

Champions Oncology stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Champions Oncology Stock Forecast for 2022

March 2022 6.86 6.93 1.02%
April 2022 7 6.86 -2%
May 2022 6.93 7 1.01%
June 2022 6.93 7.07 2.02%
July 2022 7.14 7.14 0%
August 2022 6.86 5.94 -13.41%
September 2022 6.06 8.16 34.65%
October 2022 8 6.86 -14.25%
November 2022 6.86 7.14 4.08%
December 2022 7.92 7 -11.62%

Champions Oncology Stock Forecast for 2023

January 2023 7.14 8 12.04%
February 2023 8.16 8 -1.96%
March 2023 8.16 8.08 -0.98%
April 2023 7.92 8.16 3.03%
May 2023 7.84 7.84 0%
June 2023 7.84 7.84 0%
July 2023 8.08 8.08 0%
August 2023 7.92 6.86 -13.38%
September 2023 6.86 8.91 29.88%
October 2023 9 7.84 -12.89%
November 2023 8.16 8 -1.96%
December 2023 8.08 8.16 0.99%

Champions Oncology Stock Forecast for 2024

January 2024 7.92 8.91 12.5%
February 2024 8.82 9.09 3.06%
March 2024 9 9.18 2%
April 2024 8.82 8 -9.3%
May 2024 9 8.91 -1%
June 2024 8.82 8.91 1.02%
July 2024 9 9.18 2%
August 2024 8.91 7.84 -12.01%
September 2024 8.08 10 23.76%
October 2024 10.2 9.18 -10%
November 2024 9.18 9.18 0%
December 2024 9 8.82 -2%

Champions Oncology Stock Forecast for 2025

January 2025 9.18 9.8 6.75%
February 2025 10.2 10.2 0%
March 2025 9.9 9.9 0%
April 2025 9.8 9 -8.16%
May 2025 9 9.8 8.89%
June 2025 10 10.1 1%
July 2025 9.8 10 2.04%
August 2025 9.9 9 -9.09%
September 2025 9 11 22.22%
October 2025 10.78 10.2 -5.38%
November 2025 9.9 9.8 -1.01%
December 2025 9.8 9.8 0%

Champions Oncology Stock Forecast for 2026

January 2026 9.9 10.78 8.89%
February 2026 11.11 11 -0.99%
March 2026 11.11 10.2 -8.19%
April 2026 9.8 10 2.04%
May 2026 9.8 11.22 14.49%
June 2026 11.22 10 -10.87%
July 2026 10.2 11 7.84%
August 2026 11 10 -9.09%
September 2026 10.2 11.88 16.47%
October 2026 12.12 11 -9.24%
November 2026 11.22 11 -1.96%
December 2026 11 11.11 1%

Champions Oncology Stock Forecast for 2027

January 2027 10.78 11.76 9.09%